Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell, 2012, 148(6): 1258–1270. doi: 10.1016/j.cell.2012.01.035..
DOI: 10.1016/j.cell.2012.01.035

Cabreiro F, Gems D. Worms need microbes too: microbiota, health and aging in Caenorhabditis elegans. EMBO Mol Med, 2013, 5(9): 1300–1310. doi: 10.1002/emmm.201100972..
DOI: 10.1002/emmm.201100972

Hill C, Guarner F, Reid G, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol, 2014, 11(8): 506–514. doi: 10.1038/nrgastro.2014.66..
DOI: 10.1038/nrgastro.2014.66

Chan YK, Estaki M, Gibson DL. Clinical consequences of dietinduced dysbiosis. Ann Nutr Metab, 2013, 63(Suppl 2): 28–40. doi: 10.1159/000354902..
DOI: 10.1159/000354902

Peris-Bondia F, Latorre A, Artacho A, et al. The active human gut microbiota differs from the total microbiota. PLoS One, 2011, 6(7): e22448. doi: 10.1371/journal.pone.0022448..
DOI: 10.1371/journal.pone.0022448

Fava F, Danese S. Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol, 2011, 17(5): 557–566. doi: 10.3748/wjg.v17.i5.557..
DOI: 10.3748/wjg.v17.i5.557

Guarner F, Malagelada JR. Gut flora in health and disease. Lancet, 2003, 361(9356): 512–519. doi: 10.1016/S0140-6736(03)12489-0..
DOI: 10.1016/S0140-6736(03)12489-0

Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev, 2010, 90(3): 859-904, doi: 10.1152/phys-rev.00045.2009.
DOI: 10.1152/phys-rev.00045.2009

Jimenez E, Marin M, Martin R, et al. Is meconi-um from healthy newborns actually sterile? Res Microbiol, 2008, 159(3): 187–193. doi: 10.1016/j.resmic.2007.12.007..
DOI: 10.1016/j.resmic.2007.12.007

Hu J, Nomura Y, Bashir A, et al. Diversified microbiota of meconium is affected by maternal diabetes status. PLoS One, 2013, 8(11): e78257. doi: 10.1371/journal.pone.0078257..
DOI: 10.1371/journal.pone.0078257

Collado MC, Rautava S, Aakko J, et al. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep, 2016, 6: 23129. doi: 10.1038/ srep23129..
DOI: 10.1038/ srep23129

DiGiulio DB. Diversity of microbes in amniotic fluid. Semin Fetal Neonatal Med, 2012, 17(1): 2–11. doi: 10.1016/j.siny.2011.10.001..
DOI: 10.1016/j.siny.2011.10.001

Shiozaki A, Yoneda S, Yoneda N, et al. Intestinal microbiota is different in women with preterm birth: results from terminal restriction fragment length polymorphism analysis. PLoS One, 2014, 9(11): e111374. doi: 10.1371/journal.pone.0111374..
DOI: 10.1371/journal.pone.0111374

Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A, 2010, 107(26): 11971–11975. doi: 10.1073/pnas.1002601107..
DOI: 10.1073/pnas.1002601107

Biedermann L, Rogler G. The intestinal microbiota: its role in health and disease. Eur J Pediatr, 2015, 174(2): 151–167. doi: 10.1007/s00431-014-2476-2.
DOI: 10.1007/s00431-014-2476-2

Chu D, Ma J, Prince A, et al. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat Med, 2017, 23(3): 314–326. doi: 10.1038/nm.4272..
DOI: 10.1038/nm.4272

Fouhy F, Guinane C, Hussey S, et al. High-throughput sequen cing reveals the incomplete, short-term recovery of infant gut micro-biota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother, 2012, 56(11): 5811–5820. doi: 10.1128/aac.00789-12..
DOI: 10.1128/aac.00789-12

Tanaka S, Kobayashi T, Songjinda P, et al. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol, 2009, 56(1): 80–87. doi: 10.1111/j.1574-695x.2009.00553.x..
DOI: 10.1111/j.1574-695x.2009.00553.x

Fernandez L, Langa S, Martin V, et al. The human milk microbiota: origin and potential roles in health and disease. Pharmacol Res, 2013, 69(1): 1–10. doi: 10.1016/j.phrs.2012.09.001..
DOI: 10.1016/j.phrs.2012.09.001

Backhed F, Roswall J, Peng Y, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe, 2015, 17(6): 852. doi: 10.1016/j.chom.2015.05.012..
DOI: 10.1016/j.chom.2015.05.012

Bezirtzoglou E, Tsiotsias A, Welling GW. Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe, 2011, 17(6): 478–482. doi: 10.1016/j.anaerobe.2011.03.009..
DOI: 10.1016/j.anaerobe.2011.03.009

Penders J, Vink C, Driessen C, et al. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breastfed and formula-fed infants by real-time PCR. FEMS Microbiol Lett, 2005, 243(1): 141–147. doi: 10.1016/ j.femsle.2004.11.052..
DOI: 10.1016/ j.femsle.2004.11.052

Fons M, Gomez A, Karjalainen T. Mechanisms of colonization and colonization resistance of the digestive tract. Microbial Ecol Health Dis. Suppl, 2000, 2: 240–246.

Ardatskaya MD, Dubinin AV, Minushkin ON. Terapev-ti cheskii Arkhiv – Therapeutic Archive, 2001, 2: 67–72.

Yaeshima T. Benefits of bifidobacteria to human health. Bulletin of the IDF, 1996, 313: 36–42.

Johansson M, Sjogren Y, Persson J, et al. Early col-onization with a group of Lactobacilli decreases the risk for allergy at five years of age despite allergic heredity. PLoS One, 2011, 6(8): e23031. doi: 10.1371/journal.pone.0023031..
DOI: 10.1371/journal.pone.0023031

Bisgaard H, Li N, Bonnelykke K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol, 2011, 128(3): 646–652.e5. doi: 10.1016/j.jaci.2011.04.060..
DOI: 10.1016/j.jaci.2011.04.060

Samuel B, Gordon J. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci USA, 2006, 103(26): 10011–10016. doi: 10.1073/pnas.0602187103..
DOI: 10.1073/pnas.0602187103

Abrahamsson T, Jakobsson H, Andersson A, et al. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol, 2012, 129(2): 434–440.e2. doi: 10.1016/ j.jaci.2011.10.025..
DOI: 10.1016/ j.jaci.2011.10.025

Ismail I, Oppedisano F, Joseph S, et al. Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol, 2012, 23(7): 674–681. doi: 10.1111/j.1399-3038.2012.01328.x..
DOI: 10.1111/j.1399-3038.2012.01328.x

Fujimura KE, Sitarik AR, Havstad S, et al. Neonatal gut microbiota associates with childhood multi-sensitized atopy and T cell differentiation. Nat Med, 2016, 22(10): 1187–1191. doi: 10.1038/nm.4176.
DOI: 10.1038/nm.4176

Isolauri E. Microbiota and obesity. Nestle Nutr Inst Workshop Ser, 2017, 88: 95–105. doi: 10.1159/000455217..
DOI: 10.1159/000455217

Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA, 2004, 101(44): 15718–15723. doi: 10.1073/ pnas.0407076101..
DOI: 10.1073/ pnas.0407076101

Kalliomaki M, Collado M, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr, 2008, 87(3): 534–538.

who.int [Internet]. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. Guidelines for the evaluation of probiotics in food. London, Ontario, Canada, 2002. 11 p. [cited 2017 Jun 29]. Available from: http: //www.who.int/foodsafety/ fs_management/en/probiotic_ guidelines.pdf.

Huff BA. Caveat emptor. «Probiotics» might not be what they seem. Can Fam Physician, 2004, 50: 583–587.

Presti I, D’Orazio G, Labra M, et al. Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect. Appl Microbiol Biotechnol, 2015, 99(13): 5613–5626. doi: 10.1007/s00253-015-6482-8..
DOI: 10.1007/s00253-015-6482-8

Silva M, Jacobus NV, Deneke C et al. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother, 1987, 31(8): 1231–3.

Gorbach SL, Goldin BR. Lactobacillus strains and methods of selection. US Patent. N 4839281.

Conway PL, Gorbach SL, Goldin BR. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci, 1987, 70(1): 1–12.

Issa I, Moucari R. Probiotics for antibiotic-associated diarrhea: Do we have a verdict? World J Gastroenterol, 2014 Dec 21, 20(47): 17788–17795.

Johnston BC, Supina AL, Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. CMAJ, 2006, 175(4): 377–83.

Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a rand-omized, placebo-controlled trial. J Allergy Clin Immunol, 2007 Apr, 119(4): 1019–21.

Szajewska H, Skorka A, Ruszczynski M, Gieruszczak-Bialek D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children – updated analysis of randomised controlled trials. Aliment Pharmacol Ther, 2013, 38(5): 467–476.

Усенко Д.В., Плоскирева А.А., Горелов А.В. Острые кишечные инфекции у детей в практике педиатра: возможности диагностики и терапии. Вопросы современной педиатрии, 2014, 13(3): 12-20

Raza S, Graham SM, Allen SJ et al. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J, 1995, 14(2): 107–11.

Huang J, Bousvaros A, Lee J et al. Efficacy of pro-biotic use in acute diarrhea in children, a meta-analysis. Dig Dis Sci, 2002, 47(11): 2625–34.

Van Niel CW, Feudtner C, Garrison MM et al. Lactobacillus therapy for acute infectious diar-rhea in children: a metaanalysis. Pediatrics, 2002, 109(4): 678–84.

Hojsak I, Abdovic S, Szajewska H et al. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics, 2010, 125(5): е1171–7.

Loesche WJ. Microbiology of dental decay and periodontal disease. In: Baron’s Medical Microbiology (4th Ed). University of Texas Medical Branch, 1996.

Nase L, Hatakka K, Savilahti E et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res, 2001, 35(6): 412–20.

Turroni F, Berry D, Ventura M. Editorial: Bifido-bacteria and Their Role in the Human Gut Micro-biota. Frontiers in Microbiology, 2016, 7: 2148.

Bennet R, Nord CE, Zetterstrom R. Transient colonization of the gut of newborn infants by orally administered bifidobacteria and lactobacilli. Acta Ped, 1992, 81: 784–787.

Akiyama K, Shimada M, Ishizeki S et al. Effects of administration of Bifidobacterium in extremely premature infants: development of intestinal microflora by orally administered B. longum. Acta Neonatalogica Japonica, 1994, 30: 257–263.

Uhlemann M, Heine W, Mohr C et al. Effects of oral administration on intestinal microflora in premature and newborn infants. Z Geburtshife Neonatal, 1999, 203: 213–217.

Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ, 2001, 322: 1327-9.

Näse L, Hatakka K, Savilahti E, Saxelin M, Ponka A, Poussa T, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res, 2001, 35: 412-20.

Basu S, Chatterjee M, Ganguly S, Chandra PK. Effect of Lactobacillus rhamnosus GG in persistent diarrhea in Indian children: a randomized controlled trial. J Clin Gastroenterol, 2007a, 41: 756-60.